PAA 4.88% 19.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-967

  1. 1,418 Posts.
    lightbulb Created with Sketch. 1142
    A bit of info on MND/ALS and FTD (Frontotemporal Dementia)

    ALS and FTD are both neurodegenerative diseases that affect motor neurons. However, the area where those motor neurons are found differs between the two conditions, which is why the symptoms present so differently.


    Though it’s unclear whether having one makes it more likely to have the other, 30–50% of people with ALS or FTD will develop both conditions. Researchers have found that the connection between the two, besides the neurological link, comes down to genetics.


    Specific gene changes in ALS are also found in FTD, which can explain why the motor neurons are targeted in both conditions. When a person has both, the best thing they can do is find proper treatment. Many medications are available for FTD, but they are not always effective. The options for ALS are also limited, but ongoing research continues to search for better therapies to slow the progression of ALS and reduce symptoms of FTD in people with both diseases.

    From here https://www.verywellhealth.com/als-and-frontotemporal-dementia-6931254

    Good luck to all.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.010(4.88%)
Mkt cap ! $77.20M
Open High Low Value Volume
19.5¢ 19.5¢ 18.8¢ $342.8K 1.779M

Buyers (Bids)

No. Vol. Price($)
2 52999 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 421000 3
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.